Zur Mühlen Group (ZMG) is a leader in the meat production sector in Europe, generating several billions of revenue annually from household brands. The product will be the world’s first single-ingredient meat analog. The meat analog will be launched…
Going through medical treatment is often similar to a long journey. The term “patient journey” refers to all the stages along this path – prevention, the emergence of the first symptoms of a disease, recovery, the ongoing management of a chronic…
Strategic innovation for more progress in gene and cell therapy
So far, research across medical health institutions has been complicated in Germany – not least because it was difficult to obtain relevant and comparable data. In the future, things will get easier for researchers. Of late, they have been able to…
Researchers from Charité are developing new methods to use the internal clock inside tumor cells to optimize cancer therapies
Researchers in Berlin and Düsseldorf have implicated a new gene in the progression of Huntington’s disease in a brain organoid model. The gene may contribute to brain abnormalities much earlier than previously thought. The study was published in…
Sporting activities promote our health but can lead to injuries of the musculoskeletal system if not performed correctly. This often affects the cartilage in the joints. Untreated cartilage defects can lead to osteoarthritis at older age, for which…
In the presence of the Saxon State Ministers Martin Dulig and Thomas Schmidt as well as the Mayor of Dresden Dirk Hilbert, the medical technology company Eckert & Ziegler today inaugurated its new 1,700 square meter facilities in Dresden with around…
Caresyntax, a vendor-neutral precision surgery platform, is pleased to announce raising a total commitment of $180 million through a series C extension and growth debt expansion round.
A team led by Charité – Universitätsmedizin Berlin, German Rheumatology Research Center (DRFZ) and Max Delbrück Center have defined key cells behind severe kidney damage in lupus. The research, published in Nature,* could inform future antibody…
